arrow
Y

Yoshinobu Maeda

Okayama University Hospital
H指数:43
被引数:8,895

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular Characteristics and Clinical Outcomes of ERBB2-Activating Mutation-Positive Non-Small Cell Lung Cancer: A Japanese Nationwide Real-World Cohort

ERBB2激活突变阳性非小细胞肺癌的分子特征和临床结局:一项日本全国性真实世界队列研究

2026-09-290
OA
ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer model

ULK1作为EGFR突变非小细胞肺癌模型中延迟EGFR-TKIs药物耐受的新型治疗靶点

2026-07-010
PRE
Association of ideal body weight–normalized post-transplantation cyclophosphamide dose with chronic GVHD in patients with overweight/obesity

理想体重标准化移植后环磷酰胺剂量与超重/肥胖患者慢性移植物抗宿主病的关系

2026-06-200
OA
Risk Factors for Waiting List Mortality in Lung Transplant Candidates With Post-Hematopoietic Stem Cell Transplantation Non-Infectious Pulmonary Complications

造血干细胞移植后非感染性肺部并发症患者等待移植期间死亡的危险因素

2026-05-280
PREAI
Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study

贝洛莫斯迪克作为糖皮质激素依赖/难治性cGVHD的二线或后线治疗方案的长期能随访:一项日本研究中的临床结局

2025-11-260
OAAI
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy

抗生素使用对接受免疫检查点抑制剂联合化疗的晚期非小细胞肺癌患者生存的影响

2025-08-280
PRE
Comparison of survival outcomes between chimeric antigen receptor T-cell therapy recipients with and without central nervous system involvement

比较有无中枢神经系统受累的嵌合抗原受体T细胞疗法受试者的生存结局

2025-08-050
PRE
A randomized controlled trial of conventional GVHD prophylaxis with or without teprenone for the prevention of severe acute GVHD

常规GVHD预防加或不加替普瑞酮预防严重急性GVHD的随机对照试验

2025-02-240
OAAI
Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

血浆S100A8/A9水平预测晚期非小细胞肺癌患者对免疫检查点抑制剂的反应

2025-01-200
OAAI
The Clinical Significance of Interstitial Pneumonia with Autoimmune Features in Cryptogenic Organizing Pneumonia: A Prospective Multicenter Observational Study
2024-11-150
OAAI
JALSG Ph (-) B-ALL213 Study: Pediatric-Type Chemotherapy Improves Prognosis in Adult Ph-Negative Acute Lymphoblastic Leukemia Patients, Including Older Adults

JALSG Ph (-) B-ALL213研究:儿科型化疗可改善成人Ph阴性急性淋巴细胞白血病患者的预后,包括老年患者。

BLOOD
IF23.1
2024-11-050
PRE